Joint Formulary & PAD

Intralipid - Severe systemic local anaesthetic toxicity

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
SPC
Restrictions / Comments :
Preferred

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Intralipid
Indication :
Severe systemic local anaesthetic toxicity
Group Name :
Keywords :
Lipid emulsion, cardiotoxicity
Brand Names Include :
Important Information :

https://www.toxbase.org/ . Intralipid 20%. Off-label use

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - ASPH DTC

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Intralipid is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Severe systemic local anaesthetic toxicity.

  • No records returned.